Descriptor English: | Trabectedin | ||||||
Descriptor Spanish: |
Trabectedina
| ||||||
Descriptor Portuguese: | Trabectedina | ||||||
Descriptor French: | Trabectédine | ||||||
Entry term(s): |
ET 743 ET-743 ET743 Ecteinascidin 743 NSC 684766 Yondelis |
||||||
Tree number(s): |
D03.383.246.619 D03.633.100.531.820.781 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077606 | ||||||
Scope note: | A complex structure that includes isoquinolines joined by a cyclic ester; it is a DNA-binding agent and guanine N2 alkylator derived from the marine tunicate, Ecteinascidia turbinata. Trabectedin is used for the treatment of advanced soft-tissue SARCOMA, after failure of ANTHRACYCLINES or IFOSFAMIDE drug therapy. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents, Alkylating |
||||||
Registry Number: | ID0YZQ2TCP | ||||||
Public MeSH Note: | 2019; TRABECTIDIN was indexed under DIOXOLES and TETRAHYDROISOQUINOLINES 2007-2018; and under ISOQUINOLINES 1996-2018 |
||||||
History Note: | 2019 (1996) |
||||||
DeCS ID: | 57709 | ||||||
Unique ID: | D000077606 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/04/09 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Trabectedin
- Preferred
Yondelis
- Narrower
Ecteinascidin 743
- Narrower
NSC 684766
- Narrower
Concept UI |
M0453081 |
Scope note | A complex structure that includes isoquinolines joined by a cyclic ester; it is a DNA-binding agent and guanine N2 alkylator derived from the marine tunicate, Ecteinascidia turbinata. Trabectedin is used for the treatment of advanced soft-tissue SARCOMA, after failure of ANTHRACYCLINES or IFOSFAMIDE drug therapy. |
Preferred term | Trabectedin |
Concept UI |
M0455084 |
Preferred term | Yondelis |
Concept UI |
M0260321 |
Preferred term | Ecteinascidin 743 |
Entry term(s) |
ET 743 ET-743 ET743 |
Concept UI |
M0453082 |
Preferred term | NSC 684766 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey